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CC BY-NC-ND license (http://creativAbstract We herein present a case of an intrarenal pseudoaneurysm developing 2 weeks af-
ter renal transplantation. The patient presented with hemorrhagic shock. Computed tomogra-
phy confirmed an intrarenal pseudoaneurysm with extravasation of contrast and a large
surrounding hematoma. Angiography confirmed the pseudoaneurysm, and embolization of
the segmental graft renal artery was performed. In view of the uncertain etiology and the pos-
sibility of a mycotic pseudoaneurysm, we administered empiric antimicrobial therapy. The
clinical course, investigations, and management are described. Finally, a review of the litera-
ture regarding post-transplantation pseudoaneurysms is presented.
以下是一宗於移植後 2 週出現的腎內僞動脈瘤個案，患者以出血性休克表現。當時為其安排緊急
電腦斷層攝影 (CT)，發現有一個腎內僞動脈瘤，並呈現顯影劑溢出現象，且被一大型血腫圍繞。
緊急血管攝影證實為植入腎之僞動脈瘤，同時我們對涉及的節段性動脈予以栓塞處置。基於病因
並不明確，而且不能排除黴菌性僞動脈瘤的可能性，因此我們實施了經驗性抗微生物學療法。在
本文中，我們描述了本個案的臨床歷程、相關檢查及後續處置，並指出我們在治療上所遭遇到的
困難。最後，我們對移植後僞動脈瘤的相關文獻作出了回顧。Introduction
Pseudoaneurysms developing after renal transplantation
are uncommon. They mostly occur outside the allograft,
involving the arterial anastomosis or the iliac artery.h Hospital, Waterloo Road,
rative Region.
m (H.K.K. Sin).
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of Nephrology. Published by Else
ecommons.org/licenses/by-nc-nIntrarenal pseudoaneurysms are rare, and the underlying
etiology is often uncertain. We herein report the case of an
intrarenal pseudoaneurysm developing 2 weeks after renal
transplantation.
Case Report
We describe the case of a 37-year-old man with end-stage
renal disease from membranous nephropathy. He presented
4 years ago with uremic symptoms. His creatinine level wasvier (Singapore) Pte Ltd. This is an open access article under the
d/4.0/).
Figure 1 Computed tomography of the abdomen and pelvis
revealed a 1.4 cm 4.3 cm 1.7 cm pseudoaneurysm within
the allograft.
Figure 2 Angiography via the right common femoral artery
confirmed the pseudoaneurysm, which arose from the allograft
posterior inferior segmental artery.
58 H.K.K. Sin et al.500 mmol/L (5.7 mg/dL). He had a 5-year history of hy-
pertension (incidentally discovered on routine health
check) for which he had not sought medical care. Upon
presentation, ultrasonography of the urinary system
showed no hydronephrosis. Renal biopsy revealed mem-
branous nephropathy and hypertensive changes with sig-
nificant interstitial fibrosis and tubular atrophy. He was
given both amlodipine (10 mg) and perindopril (4 mg) daily
for hypertension, and his blood pressure was maintained at
around 130/80 mmHg. He became peritoneal dialysis
dependent 2 years ago. He underwent renal transplantation
in China 1 year ago. However, donor details were unknown.
He had immediate graft function. Preoperative induction
therapy was not known. Postoperative immunosuppression
comprised the following: tacrolimus, 3.5 mg/d; mycophe-
nolate mofetil, 750 mg twice daily; and methylpredniso-
lone, 6 mg once daily. Other medications included
voriconazole (200 mg twice daily), valganciclovir (450 mg
daily), and trimethoprim/sulfamethoxazole (480 mg 3
days/wk). We were unable to clarify with his transplant
physicians the reason for giving voriconazole. He was dis-
charged on Postoperative Day 8 with creatinine level of
500 mmol/L (5.7 mg/dL). He presented to our hospital for
further care on Postoperative Day 9. Creatinine level was
400 mmol/L (4.5 mg/dL) and urine output was 6 L/d. His
renal function improved after rehydration therapy (creati-
nine 260 mmol/L). Urine microscopy was unremarkable and
proteinuria amounted to 0.5 g/d. Tacrolimus level was
12 ng/mL. Duplex ultrasonography on Postoperative Day 11
was unremarkable. He was immunoglobulin G seropositive
for cytomegalovirus and seronegative for hepatitis B, hep-
atitis C, and human immunodeficiency virus. He developed
shock on Postoperative Day 13, with a blood pressure of 90/
55 mmHg and pulse of 105 bpm. Physical examination
revealed right lower quadrant tenderness and swelling.
There was a fall in hemoglobin from 12 g/dL to 6.9 g/dL.
Crystalloid therapy and red cell transfusions were given to
stabilize his health condition. Eesophagogastroduodeno-
scopy was unremarkable. Computed tomography (CT) of
the abdomen and pelvis revealed a
1.4 cm 4.3 cm 1.7 cm pseudoaneurysm within the
allograft, and arising from it was a surrounding large
retroperitoneal hematoma extending to as far as the right
native perinephric region (Figure 1). Angiography via the
right common femoral artery confirmed the pseudoaneur-
ysm, which arose from the posterior inferior segmental
artery of the allograft (Figure 2). Microcoil embolization of
the segmental artery harboring the pseudoaneurysm was
performed. Postprocedure angiogram showed cessation of
bleeding and successful embolization of the said arterial
branch (Figure 3). Radionuclide (MAG3) scan showed an
interpolar small segmental photopenic area corresponding
to the site of the embolized pseudoaneurysm. Renal func-
tion continued to improve. Creatinine level was 272 mmol/L
on the day after embolization. Although the patient had all
along been afebrile and had no leukocytosis or positive
urine culture, procalcitonin and C-reactive protein were
both increased: 1.46 ng/mL (normal < 0.15 ng/mL) and
32 mg/L (normal < 5 mg/L), respectively. The possibility of
an infective etiology could not be ruled out with certainty,
and so empiric piperacillinetazobactam (2.25 g adminis-
tered intravenously every 8 hours initially and thenadjusted according to renal function) was given. As
mentioned earlier, we were unable to clarify the reason for
prescribing voriconazole, but we suspected that some form
of contamination or infection on the donor’s part might
have occurred and this had not been documented clearly,
and so empiric anidulafungin (200 mg intravenously for one
dose and then 100 mg daily) was given for 2 weeks. Fungal
markers, including beta-1,3-(D)-glucan and galactomannan,
Figure 3 Microcoil embolization of the segmental artery
harboring the pseudoaneurysm; postprocedure angiogram
showed successful embolization of the involved arterial
branch.
Intrarenal pseudoaneurysms 59became negative later on. Sixteen days after embolization,
there was a persistent bloody discharge from the surgical
drain (placed during transplantation). Repeat CT showed
that the retroperitoneal hematoma had slightly enlarged,
but there was no contrast extravasation. Surgical evacua-
tion of the retroperitoneal hematoma was performed under
general anesthesia. Intraoperative renal allograft biopsy
showed mild acute tubular necrosis without evidence of
infection or rejection. Culture of the hematoma yielded
methicillin-resistant coagulase-negative Staphylococcus.
Fungal culture was negative. A course of vancomycin
(dosed at 15 mg/kg intravenously every 12 hours and then
adjusted to renal function as needed) was given for 3 weeks
after surgical evacuation of the hematoma. Creatinine was
135 mmol/L (1.5 mg/dL) at 1 month post-transplantation.
Both procalcitonin and C-reactive protein levels
normalized.Discussion
Pseudoaneurysms account for 0.2% of all complications
occurring after renal transplantation. Most of them occur in
the initial weeks and months after transplantation,
although late occurring pseudoaneurysms up to 7 years
postoperatively have been reported. The anastomotic site
is the most frequently involved and may be related to
surgical technique.1 Intrarenal pseudoaneurysms are
exceedingly rare, and the most common cause of an
intrarenal pseudoaneurysm is the allograft biopsy.2
Pseudoaneurysms of an infectious etiology (mycotic
pseudoaneurysms) have been reported. The causative
organisms mostly include bacteria and fungi. Bacterial
causes include Staphylococcus aureus, Serratia,Pseudomonas aeruginosa, Escherichia coli, and Entero-
coccus, whereas fungal causes include Candida albicans,
Aspergillus, and Mucor. Sources of infection may include
the donor, contamination during the extraction and
preservation processes, surgical field contamination, and
the recipient. Donors with abdominal trauma or who had
prolonged intensive care unit admission are at an
increased risk of donating an infected kidney. Multiple
organ donation and organ extraction during asystole are
risk factors. Cultures from the donor should be traced if at
all possible. The absence of fever does not exclude the
presence of a mycotic pseudoaneurysm, and so a high
index of suspicion is needed to detect this rare infective
complication.3,4
Patients may present with pain and swelling, unex-
plained fever, ischemic symptoms in the ipsilateral lower
limb, bleeding and shock, or deterioration in renal func-
tion. Diagnosis is typically made by duplex ultrasonogra-
phy, CT angiogram, magnetic resonance angiogram, or
conventional angiography. Supportive management is
vital, and includes volume repletion, transfusion, and
antibiotic therapy as needed. In the presence of the
following factors, surgical intervention has to be consid-
ered: presence of symptoms, size of pseudoaneurysm
greater than 2.5 cm, progressive enlargement, and an in-
fectious etiology.5
Traditional open repair involves surgical resection and
vascular reconstruction to protect the ipsilateral lower
limb, but these have been associated with a high rate of
graft loss.4,6 More recently, endovascular procedures have
gained popularity. Microcoils, covered stents, and thrombin
have been used in embolizing or isolating post-
transplantation pseudoaneurysms with success.7,8
The patient in this case report underwent successful
microcoil embolization of a post-transplantation intrarenal
pseudoaneurysm. The case is remarkable in the unusual
occurrence of an intrarenal pseudoaneurysm within 2
weeks of renal transplantation. While most intrarenal
pseudoaneurysms are biopsy related, spontaneous ones are
rare. There has been only one reported case of a non-
mycotic intrarenal pseudoaneurysm in the literature. In
that particular case, the pseudoaneurysm was treated with
percutaneous thrombin injection successfully.7 In our case,
the presence of infection could not be ruled out with any
degree of certainty. Inflammatory markers were elevated.
Furthermore, we were unable to trace the reason for
starting voriconazole in China. It could be that some sort of
environmental contamination or infection in the donor
occurred but was not documented. Hence, we thought it
was prudent to give empiric antibiotic and antifungal
therapy even before cultures were available. The subse-
quent isolation of methicillin-resistant coagulase-negative
Staphylococcus guided our therapy and does, in retrospect,
suggest environmental contamination as a possibility. In
conclusion, intrarenal pseudoaneurysms constitute a rare
but potentially serious and treatable complication devel-
oping after renal transplantation. Management should focus
on treating the acute complications like bleeding and
vascular compromise, determination of the underlying eti-
ology, and the need for intervention directed toward the
pseudoaneurysm and empiric antibiotic therapy where
needed.
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